Lysosomal membrane permeability (LMP) assay
By Emma Sherrell onThis protocol details the use of a lysosomal membrane permeability (LMP) assay following cell treatment and fixation.
Immunofluorescent labeling of preformed fibril protein protocol
By Emma Sherrell onThis protocol details the use of an AlexaFluor 488 protein labeling kit to fluorescently label alpha synuclein preformed fibril protein for future application.
Western blot: Alpha-synuclein
By savannah onThis protocol describes how to detect alpha-synuclein protein in mouse dorsal medulla oblongata tissue by western blot.
Hutu80 and NCI h716 treatment with SCFAs and α synuclein Western blotting
By savannah onThis protocol describes the treatment of human enteroendocrine cell models Hutu80 and NCI h716 parental cells with SCFAs and GCase inhibitor (CBE) in order to detect the impact of SCFAs and GCAse inhibition on alpha synuclein protein expression by immunoblotting.
Human embryonic kidney cells (HEK-293)
By Emma Sherrell onThis protocol is a basic description of maintenance and culturing of human embryonic kidney cells (HEK-293).
Immunofluorescence labeling and imaging of cholinergic interneurons in post-mortem human brain tissues
By savannah onThis protocol details immunofluorescence labeling and imaging of cholinergic interneurons along with striatal astrocytes in formalin-fixed paraffin-embedded (FFPE) post-mortem human brain tissues.
Lysosomal activity DQ-Red BSA assay
By Emma Sherrell onThis protocol details the lysosomal activity DQ-Red BSA Assay. This is for treatment to live cells followed by fixation for imaging. Red signal is detected only when fluorogenic substrate is hydrolyzed by lysosomal proteases.
Imaging of cholinergic interneurons in post-mortem rodent tissue to identify striatal satellite astrocytes
By savannah onThis protocol explains steps for confocal imaging and analysis to measure inter-soma distance between interneurons/pMSNs & nearest astrocyte.
In vitro αS PFF treatment
By Emma Sherrell onThis protocol details the preparation of alpha synuclein preformed fibrils for in vitro treatment to cells for the analysis of protein uptake and processing or clearance.
Fecal sample collection
By Emma Sherrell onFecal sample collection from mice to use for gut microbiome sequencing analysis.
Operant behavior
By Emma Sherrell onThis protocol is for training mice operant conditioning to assess cognitive performance using the resources described in Matikainen-Ankney BA et al. 2021.
Preparation of pharmacological agents
By savannah onThis is a description of the preparation of different drugs for use in live animals (in vivo) or in brain slices (ex vivo).
ADP Glo protocol
By savannah onProtocol for ADP Glo (Promega) assay to measure the catalytic activity of the lipid kinase VPS34 on small unilammelar vesicles.
Model building of PI3KC3-C1/RAB1A
By savannah onDetails model building of the PI3KC3-C1/RAB!A complex using chimeraX1.5-1.6 and ISOLDE. Refinement was done using Phenix real space refinement.
Production of GTPase deficient RAB1A(Q70L) protein
By savannah onBacterial expression of the GTPase deficient Q70L mutant of human RAB1A.
Production of α-synuclein preformed fibrils (PFF)
By Emma Sherrell onThis protocol outlines the procedure to produce preformed fibrils (PFF). It has been adapted from Volpicelli-Daley et al., 2014.
Poly-ornithine/laminin substrate for neural cell culture V.2
By Emma Sherrell onThis protocol is used to create adhesive and bioactive substrate for neural cell types, low to high density neurons, astrocytes, or organoids. It is based on standard methods but includes several optimizations, use case recommendations, alternatives, and advice.
Gut-PFF surgery
By Emma Sherrell onMethod for injection of alpha-synuclein preformed fibrils in the gut in a mice.